Un Odd which commits the Government to "evaluate the opportunity to start", also through the involvement - to the extent of its competence - of the Higher Institute for Environmental Protection and Research (ISPRA), "Monitoring and consequent reporting to parliamentary committees, by the 31 December 2022, on the beneficial costs of the experimentation of GonaCon immuno-contraceptive vaccine".
This is what is foreseen by an Agenda presented by the deputy PD Luca Lotti to the Chamber, where the Budget Law. "The rules introduced during the examination in the Senate - reads the text deposited by Lotti - establish in paragraph 705 that in order to effectively combat and prevent the proliferation of some species of fauna, in the estimate of the Ministry of Health a fund has been set up with an endowment of 500.000,00 euros for the year 2022, for the introduction in Italy of the immuno-contraceptive vaccine GonaCon ".
“The purpose of the intervention - underlines the Odg - is to introduce the GonaCon vaccine, developed by Willlife services of the United States Department of Agriculture, currently only available as a solution for injection. " For these reasons the Hon. Lotti expresses doubts about the rules introduced in the Senate and therefore considers it "appropriate to provide for monitoring the benefits of the experimentation".